Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Value of EVI1 Gene Expression Level in Adult Acute Lymphoblastic Leukemia (ALL): A Study from the Group for Research on Adult ALL (GRAALL)

Claire Abbal, Raouf Ben Abdelali, Marina Lafage, Françoise Huguet, Thibaut Leguay, Olivier Spertini, Nicolas Boissel, Claude Gardin, Carlos Graux, Jean-Michel Cayuela, Marie-Laure Boulland, Nathalie Grardel, Anne Bouvier, Michel Duchosal, MD, Véronique Lhéritier, Yves Chalandon, Vahid Asnafi, MDPhD, Norbert Ifrah, Hervé Dombret, MD PhD

Blood (2014) 124 (21): 1081.

https://doi.org/10.1182/blood.V124.21.1081.1081

Published: 2014

Journal Articles

SET-NUP214 is a recurrent γδ lineage-specific fusion transcript associated with corticosteroid/chemotherapy resistance in adult T-ALL

Raouf Ben Abdelali, Anne Roggy, Thibaut Leguay, Agata Cieslak, Aline Renneville, Aurore Touzart, Anne Banos, Edouard Randriamalala, Denis Caillot, Bruno Lioure, Alain Devidas, Hossein Mossafa, Claude Preudhomme, Norbert Ifrah, Hervé Dombret, Elizabeth Macintyre, Vahid Asnafi

Blood (2014) 123 (12): 1860–1863.

https://doi.org/10.1182/blood-2013-08-521518

Published: 2014

Includes: Supplemental data

Journal Articles

Prognostic Factors Of Response and Survival To Azacitidine (AZA) +/- EPO In RBC Transfusion Dependent (TD) IPSS Low and Int-1 (LR) MDS Resistant To EPO, With Particular Emphasis Of Genetic Lesions: A Study By The GFM

Blood (2013) 122 (21): 658.

https://doi.org/10.1182/blood.V122.21.658.658

Published: 2013

Journal Articles

Heterogeneity Of Patients With Cytogenetically Normal Acute Myeloid Leukemia (CN-AML) and Nucleophosmin-1 ( NPM1 ) Gene Mutation: An Acute Leukemia French Association (ALFA) Study

Pierre Peterlin, Aline Renneville, Raouf Ben Abdelali, Olivier Nibourel, Xavier Thomas, MD, Cécile Pautas, Stéphane de Botton, Claude Gardin, Emmanuel Raffoux, Jean-Michel Cayuela, Nicolas Boissel, Christine Terré, Karine Celli-Lebras, Sylvie Castaigne, Claude Preudhomme, Hervé Dombret

Blood (2013) 122 (21): 831.

https://doi.org/10.1182/blood.V122.21.831.831

Published: 2013

Journal Articles

Towards a Purely Oncogenetic Risk Classification of Adult T-ALL: a GRAALL Study

Blood (2012) 120 (21): 881.

https://doi.org/10.1182/blood.V120.21.881.881

Published: 2012

Journal Articles

Extensive molecular mapping of TCRα/δ- and TCRβ-involved chromosomal translocations reveals distinct mechanisms of oncogene activation in T-ALL

Blood (2012) 120 (16): 3298–3309.

https://doi.org/10.1182/blood-2012-04-425488

Published: 2012

Includes: Supplemental data

Journal Articles

Pediatric-inspired intensified therapy of adult T-ALL reveals the favorable outcome of NOTCH1/FBXW7 mutations, but not of low ERG/BAALC expression: a GRAALL study

Blood (2011) 118 (19): 5099–5107.

https://doi.org/10.1182/blood-2011-02-334219

Published: 2011

Includes: Supplemental data

Journal Articles

ALL-associated JAK1 mutations confer hypersensitivity to the antiproliferative effect of type I interferon

Tekla Hornakova, Sabina Chiaretti, Muriel M. Lemaire, Robin Foà, Raouf Ben Abdelali, Vahid Asnafi, Marco Tartaglia, Jean-Christophe Renauld, Laurent Knoops

Blood (2010) 115 (16): 3287–3295.

https://doi.org/10.1182/blood-2009-09-245498

Published: 2010

Journal Articles

NOTCH1/FBXW7 Mutations, but Not Low ERG/BAALC Expression, Identify a Major Subgroup of Adult T-ALL with a Favorable Outcome: a GRAALL Study.

Raouf Ben Abdelali, MD, Agnes Buzyn, MD, PhD, Vahid Asnafi, MD, PhD, Sandrine Le Noir, PhD, Norbert Ifrah, MD, PhD, Herve Dombret, MD, PhD, Elizabeth Macintyre, MD, PhD

Blood (2009) 114 (22): 1568.

https://doi.org/10.1182/blood.V114.22.1568.1568

Published: 2009

Journal Articles

Cartridge-Based Automated BCR-ABL mRNA Quantification: Towards Simplified Standardisation.

Jean-Michel Cayuela, PhD, PharmD, Elizabeth Macintyre, MD, PhD, Meryl Darlington, Raouf Ben Abdelali, MD, Xavier Fund, Patrick Villarèse, William Piterboth, Michel Tulliez, MD, Emmanuel Raffoux, MD, Francois Sigaux, MD, PhD, Delphine Rea, MD, PhD, Dominique Bories, MD, PhD, Valerie Seror

Blood (2009) 114 (22): 4261.

https://doi.org/10.1182/blood.V114.22.4261.4261

Published: 2009

Journal Articles

C/EBPA methylation is common in T-ALL but not in M0 AML

Louis Terriou, Raouf Ben Abdelali, Christophe Roumier, Ludovic Lhermitte, John de Vos, Pascale Cornillet, Olivier Nibourel, Kheira Beldjord, Hervé Dombret, Guy Leverger, Vahid Asnafi, Claude Preudhomme, Elizabeth Macintyre

Blood (2009) 113 (8): 1864–1866.

https://doi.org/10.1182/blood-2008-09-176909

Published: 2009

Journal Articles

Prognostic Value of Minimal Residual Disease by Real-Time Quantitative PCR in AML with CBFB-MYH11 Rearrangement: The French Experience.

Romain Guièze, Aline Renneville, Jean-Michel Cayuela, Raouf Ben Abdelali, Nicolas Boissel, Marie-Thérèse Rubio, Françoise Mazingue, Elizabeth A. Macintyre, François Sigaux, Pierre Fenaux, Hervé Dombret, Claude Preudhomme

Blood (2007) 110 (11): 3496.

https://doi.org/10.1182/blood.V110.11.3496.3496

Published: 2007

Journal Articles

Efficacy of Imatinib-Based Therapy in a Patient with Resistant NUP214-ABL1 T-Cell Acute Lymphoblastic Leukemia.

Jacques Delaunay, MD, Raouf Ben Abdelali, MD, Cyrille Touzeau, MD, Patrice Chevallier, MD, Guillaume Thierry, MD, Steven Le Gouill, MD, PhD, Sameh Ayari, MD, Jean-Luc Harousseau, MD, Elisabeth Macintyre, MD, PhD, Herve Avet Loiseau, MD, PhD, Herve Dombret, MD, Pascaline Talmant, MD

Blood (2007) 110 (11): 4329.

https://doi.org/10.1182/blood.V110.11.4329.4329

Published: 2007

Journal Articles

Novel Spliced MLL Fusions Have Been Identified Involving the MLL Partner Genes ELL, EPS15, MLLT3, and SEPT5.

Claus Meyer, PhD, Eric Kowarz, Wajih Brahim, MD, Renate Grümayer, MD, Raouf Ben-Abdelali, MD, Etienne De Braekeleer, Marc De Braekeleer, PhD, Elizabeth A. Macintyre, PhD, Eric Delabesse, PhD, Theo Dingermann, PhD, Thomas Klingebiel, MD, Rolf Marschalek, PhD

Blood (2007) 110 (11): 978.

https://doi.org/10.1182/blood.V110.11.978.978

Published: 2007

Journal Articles

Novel activating JAK2 mutation in a patient with Down syndrome and B-cell precursor acute lymphoblastic leukemia

Sebastien Malinge, Raouf Ben-Abdelali, Catherine Settegrana, Isabelle Radford-Weiss, Marianne Debre, Kheira Beldjord, Elizabeth A. Macintyre, Jean-Luc Villeval, William Vainchenker, Roland Berger, Olivier A. Bernard, Eric Delabesse, Virginie Penard-Lacronique

Blood (2006) 109 (5): 2202–2204.

https://doi.org/10.1182/blood-2006-09-045963

Published: 2006

Includes: Supplemental data

NARROW

Value of EVI1 Gene Expression Level in Adult Acute Lymphoblastic Leukemia (ALL): A Study from the Group for Research on Adult ALL (GRAALL)

SET-NUP214 is a recurrent γδ lineage-specific fusion transcript associated with corticosteroid/chemotherapy resistance in adult T-ALL

Prognostic Factors Of Response and Survival To Azacitidine (AZA) +/- EPO In RBC Transfusion Dependent (TD) IPSS Low and Int-1 (LR) MDS Resistant To EPO, With Particular Emphasis Of Genetic Lesions: A Study By The GFM

Heterogeneity Of Patients With Cytogenetically Normal Acute Myeloid Leukemia (CN-AML) and Nucleophosmin-1 ( NPM1 ) Gene Mutation: An Acute Leukemia French Association (ALFA) Study

Towards a Purely Oncogenetic Risk Classification of Adult T-ALL: a GRAALL Study

Extensive molecular mapping of TCRα/δ- and TCRβ-involved chromosomal translocations reveals distinct mechanisms of oncogene activation in T-ALL

Pediatric-inspired intensified therapy of adult T-ALL reveals the favorable outcome of NOTCH1/FBXW7 mutations, but not of low ERG/BAALC expression: a GRAALL study

ALL-associated JAK1 mutations confer hypersensitivity to the antiproliferative effect of type I interferon

NOTCH1/FBXW7 Mutations, but Not Low ERG/BAALC Expression, Identify a Major Subgroup of Adult T-ALL with a Favorable Outcome: a GRAALL Study.

Cartridge-Based Automated BCR-ABL mRNA Quantification: Towards Simplified Standardisation.

C/EBPA methylation is common in T-ALL but not in M0 AML

Prognostic Value of Minimal Residual Disease by Real-Time Quantitative PCR in AML with CBFB-MYH11 Rearrangement: The French Experience.

Efficacy of Imatinib-Based Therapy in a Patient with Resistant NUP214-ABL1 T-Cell Acute Lymphoblastic Leukemia.

Novel Spliced MLL Fusions Have Been Identified Involving the MLL Partner Genes ELL, EPS15, MLLT3, and SEPT5.

Novel activating JAK2 mutation in a patient with Down syndrome and B-cell precursor acute lymphoblastic leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only